US$ 29.30
dehydration on glp 1 a GLP-1, can feel like absolute death and here's why ๐ 1๏ธโฃ Slower gastric emptying GLP-1s already slow digestion. Add dehydration and food + meds just sit there longer, which GLP-1 Medication Risks: Dehydration &
Description
Semaglutide & Tirzepatide injections at Elysium Chicago for sustainable fat loss.
And a full micronutrient panel (B12, B6, folate, iron, zinc, magnesium, vitamin D3, biotin) to cover what reduced food intake takes away

3rd-party tested for accuracy

Safety Considerations and Managing Risks GI Side Effects: Transient issues like nausea, vomiting, and diarrhoea are common, especially during initial dose escalation

Both human and animal studies reported inconsistent BP response to acute administration but showed hypotensive effect of chronic administration of GLP-1/ GLP-1 RAs
The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications
